Stocks TelegraphStocks Telegraph
Stock Ideas

AMPH Stock Performance and Key Statistics

NASDAQ : AMPH

Amphastar Pharmaceuticals

$29.26
0.63+2.20%
At Close 4:00 PM
60.86
BESG ScoreESG Rating

stock performance chart

AMPH Fundamental Analysis

Based on recent data, Amphastar Pharmaceuticals, Inc. (AMPH) shows an Average True Range (ATR) of 0.98 and an Enterprise Value of 2.48B. Its average trading volume over the past 3 months is 380.42K, indicating liquidity. These fundamental metrics provide insight into AMPH's underlying financial health and market activity.

ATR0.98
Enterprise Value2.48B
Avg Vol (3 Months)380.42K
Avg Vol (10 Days)375.81K

AMPH Technical Analysis Indicators

Amphastar Pharmaceuticals, Inc. (AMPH) technical indicators as of February 7, 2026: the SMA 20 is 7.5%, SMA 50 at 8.65%, and SMA 200 at 13.71%. The RSI 14 value is 67.05, suggesting its current momentum. These technical analysis signals help assess AMPH's price trends and potential future movements.

SMA 207.5%
SMA 508.65%
SMA 20013.71%
RSI 1467.05

AMPH Stock Performance Overview

Amphastar Pharmaceuticals, Inc. (AMPH) stock performance overview as of February 7, 2026: The 52-week high is $32.95 (currently -12.45% below), and the 52-week low is $20.39 (currently 43.54% above). Over the past year, AMPH's performance is -27.23%, compared to the S&P 500's 8.57% change.

52-Week High32.95
52-Week High Chg-12.45%
52-Week Low20.39
52-Week Low Chg+43.54%
S&P 500 52-Week Chg8.57%

Amphastar Pharmaceuticals, Inc. (AMPH) Historical Stock Performance

According to market data, Amphastar Pharmaceuticals, Inc. (AMPH) stock's recent performance metrics show that over the last month, AMPH is -0.46%, with a Year-to-Date (YTD) performance of -3.1%. Over the past year, the stock has seen a -27.23% change. These figures summarize AMPH's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High29.4629.5229.5231.2632.9529.52
Low26.3425.4223.6720.720.3925.42
Performance-11.73%-0.46%+9.13%+22.46%-27.23%-3.10%

Industry Analysis and Valuation

According to current financial data, AMPH stock's P/E (TTM) ratio is 12.20, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for AMPH, including P/S (1.86), P/B (1.75), and P/FCF (11.89), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationAMPHSector MedianIndustry AvgS&P 500
P/E (TTM)12.2-1.2313.1432.59
P/S (TTM)1.863.716.115.98
P/B (TTM)1.750.2223.375.47
P/FCF (TTM)11.89-1329.16-2.6532.07

Frequently Asked Questions

How is AMPH price-to-earnings ratio currently?
AMPH has a current P/E ratio of 12.2
How are AMPH's price-to-sale and price-to-book ratios?
The AMPH stock has a trailing twelve month price-to sales (P/S) ratio of 1.86 while its price-to-book (P/B) value is 1.75.
Is Amphastar Pharmaceuticals, Inc.'s price-to-cashflow ratio high or low?
AMPH's price-to-free-cashflow (P/FCF) ratio is 11.89, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for AMPH?
Based on AMPH's recent bid, its distance from 20 days simple moving average is 7.5%. It is 8.65% apart from 50 days simple moving average, and it is 13.71% apart from 200 days simple moving average.
What is the 52-week price range for AMPH?
The 52-week high for AMPH is $32.95 which is -12.45% away from the current price level whereas the distance of that from the 52-week low of $20.39 stands at 43.54%.
An overview of AMPH's stock performance: how did it fare?
The performance of AMPH stock was not encouraging with most of its significant price indicators in red. Amphastar Pharmaceuticals, Inc.(NASDAQ: AMPH) shares have moved upward +2.20% or $0.63 in the latest trading session and have lost -3.1% year-to-date (YTD). The stock has lost nearly -27.23% over the past year. After moving 9.13% over the trailing 3-month period, the stock is 22.46% higher in the 6-month period. Looking at its performance over the shorter term, it'slost -11.73% a week and -0.46% a month.
What is AMPH's 14-day relative strength index (RSI)?
The current 14-day RSI for AMPH stock is 67.05. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For AMPH, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Amphastar Pharmaceuticals, Inc. (AMPH) has a 14-day ATR of 0.98.
What is AMPH's current enterprise value?
After closing at $28.63 with 45.95M of its shares outstanding, the current enterprise value of AMPH is roughly 2.48B.
Over the past year, how has the stock price of AMPH changed?
Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) is down -27.23% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 8.57%. AMPH stock price is also down -3.1% on its value in year-to-date trading.
What is the average trading volume for AMPH shares?
The number outstanding shares of AMPH is 45.95M, and of these 76.02% shares are freely available for trading. On average, AMPH stock has traded 375.81K shares per day for the past 10 days. A total of 337.34K shares changed hands during the last trading session with the average session volume of 383.36K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph